About PreludeDx
PreludeDx is a company based in Laguna Hills (United States) founded in 2009.. PreludeDx has raised $51.65 million across 7 funding rounds from investors including GenesisCare and Evidity Health Capital. The company has 33 employees as of December 31, 2021. PreludeDx offers products and services including DCISionRT. PreludeDx operates in a competitive market with competitors including Raysearch laboratories, Miltel, OncoStem, Inbiomotion and POC Medical Systems, among others.
- Headquarter Laguna Hills, United States
- Employees 33 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Prelude Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$51.65 M (USD)
in 7 rounds
-
Latest Funding Round
$5 M (USD), Series B
Oct 30, 2025
-
Investors
GenesisCare
& 1 more
-
Employee Count
33
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PreludeDx
PreludeDx offers a comprehensive portfolio of products and services, including DCISionRT. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Predicts radiation benefit and recurrence risk for DCIS patients.
Unlock access to complete
Unlock access to complete
Funding Insights of PreludeDx
PreludeDx has successfully raised a total of $51.65M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $5 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series B — $5.0M
-
First Round
First Round
(15 Mar 2016)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Series B - PreludeDx | Valuation |
investors |
|
| Mar, 2022 | Amount | Series B - PreludeDx | Valuation | Evidity Health Capital |
|
| Jul, 2021 | Amount | Series B - PreludeDx | Valuation | GenesisCare |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PreludeDx
PreludeDx has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include GenesisCare and Evidity Health Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Late-stage venture capital and growth equity investments are managed by Evidity Health Capital.
|
Founded Year | Domain | Location | |
|
A chain of multi-speciality clinics is operated in Australia.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PreludeDx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PreludeDx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Preludedx Comparisons
Competitors of PreludeDx
PreludeDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Raysearch laboratories, Miltel, OncoStem, Inbiomotion and POC Medical Systems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based radiation therapy software is developed for oncology professionals.
|
|
| domain | founded_year | HQ Location |
Telomere tests for aging detection and cellular senescence are provided.
|
|
| domain | founded_year | HQ Location |
Prognostic tests for cancer detection and recurrence risk are developed.
|
|
| domain | founded_year | HQ Location |
Biomarkers for predicting bone metastasis in cancer patients are developed.
|
|
| domain | founded_year | HQ Location |
Develops rapid tools for breast cancer detection and disease screening worldwide.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Preludedx
Frequently Asked Questions about PreludeDx
When was PreludeDx founded?
PreludeDx was founded in 2009 and raised its 1st funding round 7 years after it was founded.
Where is PreludeDx located?
PreludeDx is headquartered in Laguna Hills, United States. It is registered at Laguna Hills, California, United States.
Who is the current CEO of PreludeDx?
Daniel Forche is the current CEO of PreludeDx.
Is PreludeDx a funded company?
PreludeDx is a funded company, having raised a total of $51.65M across 7 funding rounds to date.
How many employees does PreludeDx have?
As of Dec 31, 2021, the latest employee count at PreludeDx is 33.
What does PreludeDx do?
Founded in 2009 and headquartered in Laguna Hills, United States, PreludeDx operates in the medical diagnostics sector. Risk assessment tests for early-stage breast cancer are developed and offered, with the DCISionRT product focused on ductal carcinoma in situ (DCIS) patients. Disease-associated biomarkers and proprietary algorithms are utilized to classify patients into high- and low-risk groups, while treatment predictions for cancer patients are also generated through the system.
Who are the top competitors of PreludeDx?
PreludeDx's top competitors include Raysearch laboratories, OncoStem and Biotheranostics.
What products or services does PreludeDx offer?
PreludeDx offers DCISionRT.
Who are PreludeDx's investors?
PreludeDx has 2 investors. Key investors include GenesisCare, and Evidity Health Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.